Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis

被引:3
作者
Montastruc, JL [1 ]
Pathak, A [1 ]
Bagheri, H [1 ]
机构
[1] CHU Toulouse, Serv Pharmacol Clin, Ctr Midi Pyrenees Pharmacovigilance Pharmacoepide, Fac Med, Toulouse, France
关键词
D O I
10.1016/S0035-3787(04)70843-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:19 / 21
页数:3
相关论文
共 18 条
[1]   MITRAL-VALVE DISEASE-ASSOCIATED WITH LONG-TERM ERGOTAMINE USE [J].
AUSTIN, SM ;
ELHAYEK, A ;
COMIANOS, M ;
TAMULONIS, DJ .
SOUTHERN MEDICAL JOURNAL, 1993, 86 (10) :1179-1181
[2]   CARDIAC MURMURS AND ENDOCARDIAL FIBROSIS ASSOCIATED WITH METHYSERGIDE THERAPY [J].
BANA, DS ;
MACNEAL, PS ;
LECOMPTE, PM ;
SHAH, Y ;
GRAHAM, JR .
AMERICAN HEART JOURNAL, 1974, 88 (05) :640-655
[3]   Drug-induced respiratory disorders: Incidence, prevention and management [J].
Ben-Noun, L .
DRUG SAFETY, 2000, 23 (02) :143-164
[4]   Pergolide-induced pleuropulmonary fibrosis [J].
Bleumink, GS ;
van der Molen-Eijgenraam, M ;
Strijbos, JH ;
Sanwikarja, S ;
van Puijenbroek, JP ;
Stricker, BHC .
CLINICAL NEUROPHARMACOLOGY, 2002, 25 (05) :290-293
[5]   Reversible cardiac valve abnormalities with pergolide treatment. [J].
Calomne, V ;
Dupuis, MJM ;
Muller, T ;
Kempinere, F .
REVUE NEUROLOGIQUE, 2004, 160 (01) :81-82
[6]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[7]  
Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75
[8]   Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (Cabergoline) for Parkinson's disease [J].
Ling, LH ;
Ahlskog, JE ;
Munger, TM ;
Limper, AH ;
Oh, JK .
MAYO CLINIC PROCEEDINGS, 1999, 74 (04) :371-375
[9]   METHYSERGIDE-INDUCED HEART-DISEASE - CASE OF MULTI-VALVULAR AND MYOCARDIAL FIBROSIS [J].
MASON, JW ;
BILLINGHAM, ME ;
FRIEDMAN, JP .
CIRCULATION, 1977, 56 (05) :889-890
[10]   CURRENT STATUS OF DOPAMINE AGONISTS IN PARKINSONS-DISEASE MANAGEMENT [J].
MONTASTRUC, JL ;
RASCOL, O ;
SENARD, JM .
DRUGS, 1993, 46 (03) :384-393